US 11268154
Methods for the identification, evaluation and treatment of patients having multiple myeloma
granted A61KA61K31/454A61K31/573
Quick answer
US patent 11268154 (Methods for the identification, evaluation and treatment of patients having multiple myeloma) held by Takeda Pharmaceutical Company Limited expires Mon Mar 03 2042 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Takeda Pharmaceutical Company Limited
- Grant date
- Tue Mar 08 2022 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Mar 03 2042 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 19
- CPC classes
- A61K, A61K31/454, A61K31/573, A61K31/69, A61K38/05